Center for Physiotherapy, Rehabilitation and Re-Education (Ce.Fi.R.R.), Venue "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
Responsible Research Hospital, 86100 Campobasso, Italy.
Medicina (Kaunas). 2024 Jul 5;60(7):1099. doi: 10.3390/medicina60071099.
: Irritable bowel syndrome (IBS) is an invasive and potentially disabling syndrome characterized by a multitude of symptoms capable of reducing the quality of life of patients. Among the most disabling symptoms of IBS is certainly physical pain, which manifests itself mainly at the abdominal level but can also appear in other areas of the body, particularly in the form of chronic low-back pain (CLBP). Among the non-invasive methods of treating organ-specific pathologies and organ-related musculoskeletal problems, the use of Bioresonance Therapy (BT)-based on the administration of self-modulating Extremely Low-Frequency Electromagnetic Fields, capable of determining a rebalance of bio-electrical and metabolic activity in the presence of various functional alterations-is currently gaining acceptance. Therefore, we decided to monitor results obtained from patients suffering from IBS and CLBP subjected to a cycle of treatments with BT. : We monitored 20 patients (12 women and 8 men, average age of 51 years) suffering from CLBP and other visceral symptoms related to IBS. Patients were monitored through the use of the Bristol Stool Form Scale (BSFS), the Fecal Calprotectin test and the Short-Form Health Survey 36 (SF-36), collected before (T0) and after (T1) the execution of the cycle of treatments. They undertook a treatment protocol consisting of eight sessions of BT carried out over about a month. : At the end of the treatments with BT, it was possible to observe a general and significant improvement in all the parameters observed, as well as a close inversely proportional correlation between the Calprotectin values detected and the quality of life experienced by the patients in relation to their perceived IBS symptoms. : Overall, our pilot study would seem to suggest a potential beneficial effect of BT in modulating organic and musculoskeletal symptoms derived from IBS.
肠易激综合征（IBS）是一种具有侵袭性且可能导致残疾的综合征，其特征为多种症状，这些症状能够降低患者的生活质量。在 IBS 的诸多致残症状中，无疑当属躯体疼痛，其主要表现为腹部症状，但也可能出现在身体的其他部位，特别是以慢性下腰痛（CLBP）的形式出现。在针对特定器官的病理和与器官相关的肌肉骨骼问题的非侵入性治疗方法中，基于自调谐极低频电磁场的生物共振治疗（BT）的应用正在得到认可，这种方法能够在存在各种功能改变的情况下，确定生物电和代谢活动的再平衡。因此，我们决定对接受 BT 治疗周期的 IBS 和 CLBP 患者的治疗结果进行监测。
我们监测了 20 名患者（12 名女性和 8 名男性，平均年龄 51 岁），他们患有 CLBP 和其他与 IBS 相关的内脏症状。患者通过使用布里斯托粪便形态量表（BSFS）、粪便钙卫蛋白检测和健康调查简表 36（SF-36）进行监测，在治疗前（T0）和治疗后（T1）收集这些数据。他们接受了为期约一个月的 8 次 BT 治疗方案。
在 BT 治疗结束时，我们观察到所有观察到的参数都有了显著的整体改善，同时，检测到的钙卫蛋白值与患者的生活质量之间呈密切的负相关，这种相关与他们感知到的 IBS 症状有关。
总的来说，我们的初步研究似乎表明 BT 在调节源自 IBS 的有机和肌肉骨骼症状方面具有潜在的有益效果。
